Inactive Instrument

Rafarma Pharmaceuticals, Inc. Stock Other OTC

Equities

RAFA

US75062C1009

Dynamic Chart
RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park CI
Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers CI
Rafarma Pharmaceuticals, Inc. Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan CI
Vaccines Lab Sdn Bhd Enters Master Strategic Joint Venture Agreement with Rafarma Pharmaceuticals Inc CI
Rafarma Pharmaceuticals, Inc. Signs a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia CI
R. & D. Biocogency Laboratories Inc. Ltd. completed the acquisition of an unknown majority stake in Rafarma Pharmaceuticals, Inc.. CI
Rafarma Pharmaceuticals, Inc. Appoints Ilia Shpurov as Chairman of the Board CI
Rafarma Establishes Thailand Corporate Entity for Merger and Expansion Projects CI
R. & D. Biocogency Laboratories Inc. Ltd. agreed to acquire an unknown majority stake in Rafarma Pharmaceuticals, Inc.. CI
Rafarma Pharmaceuticals, Inc. Announces Finalization of the Agreement with Destination Marketing Group Co. Ltd CI
Rafarma Pharmaceuticals, Inc. Announces Commencement of Tests for Its New Product Hempysleep CI
Rafarma Appoints Vladislav N. Laskav as Board Member CI
Rafarma Pharmaceuticals, Inc. Agrees Terms to Open Its First Specialized Cannabis Spa in Europe CI
Rafarma Pharmaceuticals Inc. Officially Begun Research Programs with Khon Kaen University in Thailand CI
Rafarma Announces Cooperative Research Programs with the Faculty of Medicine, Khon Kaen University, Thailand CI
More news